Interleukin-10 in murine metal-induced systemic autoimmunity

Clinical and Experimental Immunology

Volumn 141, Issue 3, 2005, Pages 422-431

  Haggqvist B ^a   Hultman, Per ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmunity; Interleukin 10; Mercury; Mice; Silver

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; CHROMATIN ANTIBODY; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; MERCURY; MESSENGER RNA; METAL; RECOMBINANT INTERLEUKIN 10; SILVER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; IMMUNE COMPLEX DEPOSITION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SPLEEN WEIGHT; TREATMENT OUTCOME; WILD TYPE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHROMATIN; COLON; DISEASE SUSCEPTIBILITY; DNA, SINGLE-STRANDED; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-4; LYMPH NODES; MERCURY; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, ANIMAL; RECOMBINANT PROTEINS; RNA, MESSENGER; SILVER;

EID: 23044492601     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02878.x     Document Type: Article

References (51)

1. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000; 85:9-18.
2. Kunkel SL, Godessart N. Chemokines in autoimmunity: from pathology to therapeutics. Autoimmun Rev 2002; 1:313-20.
3. Krause I, Valesini G, Scrivo R, Shoenfeld Y. Autoimmune aspects of cytokine and anticytokine therapies. Am J Med 2003; 115:390-7.
4. Taylor PC, Williams RO, Maini RN. Anti-TNF alpha therapy in rheumatoid arthritis - current and future directions. Curr Dir Autoimmun 2000; 2:83-102.
5. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-95.
6. Dumoutier L, Renauld JC. Viral and cellular interleukin-10 (IL-10) -related cytokines: from structures to functions. Eur Cytokine Netw 2002; 13:5-15.
7. Tone M, Powell MJ, Tone Y, Thompson SA, Waldmann H. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol 2000; 165:286-91.
8. Moore K, de Waal Malefy R, Coffman R, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol 2001; 19:683-765.
9. Riley JK, Takeda K, Akira S, Schreiber RD. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 1999; 274:16513-21.
10. Mocellin S, Marincola F, Rossi CR, Nitti D, Lise M. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 2004; 15:61-76.
11. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71:169-75.
12. Cua DJ, Groux H, Hinton DR, Stohlman SA, Coffman RL. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J Exp Med 1999; 189:1005-10.
13. Hultman P, Johansson U, Dagnaes-Hansen F. Murine mercury-induced autoimmunity. the role of T-helper cells. J Autoimmun 1995; 8:809-24.
14. Pollard KM, Hultman P. Effects of mercury on the immune system. In: Sigel H, Sigel A, eds. Mercury and its effects on environment and biology, vol. 34. Basel: Marcel Dekker, 1997:421-40.
15. Kono DH, Park MS, Szydlik A et al. Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J Immunol 2001; 167:2396-403.
16. 2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int Arch Allergy Appl Immunol 1989; 90:47-53.
17. Goldman M, Druet P, Gleichmann E. A role for Th2 cells in systemic autoimmunity. insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12:223-7.
18. d mice is mediated by interferon-gamma (IFN-γ). Clin Exp Immunol 1997; 109:149-56.
19. Bagenstose L, Salgame P, Monestier M. IL-12 down-regulate autoantibody production in mercury-induced autoimmunity. J Immunol 1998; 160:1612-7.
20. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E. Il-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991; 146:3006-11.
21. Bagenstose L, Salgame P, Monestier M. Mercury-induced autoimmunity in the absence of interleukin-4. Clin Exp Immunol 1998; 114:9-12.
22. Kono D, Balomenos D, Perason D et al. Systemic autoimmunity indiced by mercury is dependent on IFN-gamma but not Th1/Th2 imbalance. J Immunol 1998; 161:234-40.
23. Häggqvist B, Hultman P. Murine metal-induced systemic autoimmunity: baseline and stimulated cytokine mRNA expression in genetically susceptible and resistant strains. Clin Exp Immunol 2001; 126:157-64.
24. Gillespie K, Saoudi A, Kuhn J et al. Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur J Immunol 1996; 26:2388-92.
25. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
26. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173:507-10.
27. Marchant A, Bruyns C, Vandenabeele P et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994; 24:1167-71.
28. Johansson U, Hansson-Georgiadis H, Hultman P. Murine silver-induced autoimmunity: silver shares induction of antinucleolar antibodies with mercury, but causes less activation of the immune system. Int Arch Allergy Appl Immunol 1997; 113:432-43.
29. Hultman P, Eneström S. Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits. Clin Exp Immunol 1988; 71:269-74.
30. Burlingame RW, Rubin RL. Subnucleosome structure as substrates in enzyme-linked immunosorbent assays. J Immunol Methods 1990; 134:187-99.
31. Hultman P, Ganowiak K, Turely SJ, Pollard KM. Genetic susceptibility to silver-induced antifibrillarin autoantibodies in mice. Clin Immunol Immunopathol 1995; 77:291-7.
32. Conti P, Kempuraj D, Kandere K et al. IL-10, an inflammatory/ inhibitory cytokine, but not always. Immunol Lett 2003; 86:123-9.
33. Zhou L, Nazarian AA, Smale ST. Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol Cell Biol 2004; 24:2385-96.
34. Häggqvist B, Hultman P. Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response. Clin Exp Immunol 2003; 134:202-9.
35. Nagelkerken L, Blauw B, Tielemans M. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int Immunol 1997; 9:1243-51.
36. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994; 24:1434-40.
37. Cuzzocrea S, Mazzon E, Dugo L et al. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis. Eur Cytokine Netw 2001; 12:568-80.
38. Hultman P, Bell LJ, Eneström S, Pollard KM. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2-recombinant strains. Clin Immunol Immunopathol 1992; 65:98-109.
39. Abedi-Valugerdi M, Moller G. Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. Int Immunol 2000; 12:1425-30.
40. Hanley GA, Schiffenbauer J, Sobel ES. Class II haplotype differentially regulates immune response in HgCl2-treated mice. Clin Immunol Immunopathol 1997; 84:328-37.
41. Hu H, Moller G, Abedi-Valugerdi M. Mechanism of mercury-induced autoimmunity. both T helper 1- and T helper 2-type responses are involved. Immunology 1999; 96:348-57.
42. Baccala R, Kono DH, Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev 2005; 204:9-26.
43. Spencer SD, Di Marco F, Hooley J et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 1998; 187:571-8.
44. Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10 (-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2000; 278:G829-33.
45. Berg DJ, Davidson N, Kuhn R et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4 (+) TH1-like responses. J Clin Invest 1996; 98:1010-20.
46. Silver S. Bacterial silver resistance, molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003; 27:341-53.
47. Jansson G, Harms-Ringdahl M. Stimulating effects of mercuric- and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Rad Res Commun 1993; 18:87-98.
48. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998; 160:5213-20.
49. Batteux F, Trebeden H, Charreire J, Chiocchia G. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. Eur J Immunol 1999; 29:958-63.
50. Goudy KS, Burkhardt BR, Wasserfall C et al. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J Immunol 2003; 171:2270-8.
51. Hultman P, Nielsen JB. The effect of dose, gender, and non-H-2 genes in murine mercury-induced autoimmunity. J Immunol 2001; 17:27-37.